Globus Medical (NYSE: GMED) reported Q2 EPS of $0.25, in-line with the analyst estimate of $0.25. Revenue for the quarter came in at $133.6 million versus the consensus estimate of $126.89 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.